Skip to the main content.
HUB of
Biotherapeutic
Intelligence™
Antibody Discovery Services
Overview
Target Analysis & Immunization
Antibody Discovery & Characterization
Developability Profiling
Optimization & Engineering
Preclinical Services
Protein Manufacturing
Overview

 

Catalog Products
Online Store
HUB of
Biotherapeutic
Intelligence™
AI Technology
LENSai Applications
The LENSai Difference
See our latest upcoming event.
Tell me moreto Events
HUB of
Biotherapeutic
Intelligence™
Applications
Insights
See our latest upcoming event.
Tell me moreto Events
HUB of
Biotherapeutic
Intelligence™
Resources
Antibody Discovery Resources
AI Technology Resources
IPA Collective
Resource Spotlight
See our latest upcoming event.
Tell me moreto Events
HUB of
Biotherapeutic
Intelligence™
Company
Overview
Leadership
Investor Relations
Careers
Locations
Contact Us
News
News & Press Releases
Events
See our latest upcoming event.
Tell me moreto Events

In the News

Contact Us

IPA News
May 9th, 2022
IPA’s Subsidiary BioStrand Secures Second VLAIO Research Grant
IPA subsidiary BioStrand receives grant to expand LENSai platform by linking HYFTs™ with 3D protein structure and function Diepenbeek, (Belgium), May 9, 2022 – IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA) (TSXV: IPA) is...
January 10th, 2022
2022 BIO Partnering at JPM
Join ImmunoPrecise for 2022 BIO Partnering at JPM. The event is being held virtually from January 10-14, 2022. This event provides attendees with tools to efficiently arrange meetings and make connections in the life science industry. To learn more...
January 9th, 2022
21st Annual PepTalk
ImmunoPrecise will be attending the 21st Annual PepTalk 2022, the Protein Science and Production Week, from January 17-19th, 2022. PepTalk is the largest annual gathering of protein science researchers in the world. The conference focuses on...
January 3rd, 2022
ImmunoPrecise Antibodies Announces Grant of Stock Options
VICTORIA, British Columbia – January 3, 2022–IMMUNOPRECISE ANTIBODIES LTD. (“IPA” or the “Company”) (NASDAQ: IPA) (TSXV: IPA), a leader in full-service, therapeutic antibody discovery, today announced that its board of directors has approved the...
December 7th, 2021
Antibody Engineering & Therapeutics – San Diego
ImmunoPrecise (IPA) will be attending the Antibody Engineering & Therapeutics conference being hosted December 12-16, 2021. Delivered as a Hybrid Event, available in-person at the Marriott Marquis San Diego as well as online. IPA will be hosting an...
December 7th, 2021
ImmunoPrecise Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2022
The Company to host an earnings conference call via webcast on December 13, 2021 at the close of market VICTORIA, BRITISH COLUMBIA December 7th, 2021 / – IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (NASDAQ: IPA) (TSX VENTURE: IPA) a...
November 24th, 2021
The BioTech Pharma Summit
ImmunoPrecise (IPA) will be attending The BioTech Pharma Summit November 29-30, 2021 being held in Porto, Portugal and virtually. BioTech Pharma Summit brings together a large number of pharma industry buyers and sellers all under one roof. To learn...
November 24th, 2021
Europe HubXchange 2021
We will be attending Europe HubXchange on November 30, 2021. HubXchange specializes in delivering high-level content, intelligence, and connections to the global Life Sciences community by hosting outstanding business Xchanges. These meetings are a...
October 28th, 2021
European Antibody Congress
ImmunoPrecise Antibodies (IPA) will attend the Festival of Biologics held at the Congress Centre, Basel November 9-11th. The Festival of Biologics is a combination of four conferences: the European Antibody Congress, the World Immunotherapy...
October 12th, 2021
13th Annual PEGS Europe
ImmunoPrecise will be exhibiting at the 13th annual PEGS Europe. PEGS (Protein & Antibody Engineering Summit) is one of the most significant European events for all aspects of proteins and antibody engineering, offering keynote speakers, seminars,...
July 19th, 2021
Immunology 101: Innate and Adaptive Immunity Explained
Our body has a powerful army that protects it from various types of threats including viruses, bacteria, fungi, and parasites: this is the immune system. It has long been known that people who survive an infectious disease will develop protection...
June 16th, 2021
6th Annual CAR-TCR Summit
The 6th Annual CAR-TCR Summit returns in 2021 as the industry-leading comprehensive forum with one goal: to engineer a disease-free world. At the event, over 150 speakers will lead discussions on many topics from commercial pipeline development to...
June 12th, 2021
Upcoming Webinar Hosted by the Antibody Society
Dr. Debby Kruijsen and Dr. Ilse Roodink will be presenting the webinar Staying ahead of the virus: From a multispecies discovery strategy to highly efficacious, clinically suitable multi-antibody cocktails targeting SARS-CoV-2, June 17th at 8 am...
June 10th, 2021
Biologics UK: In-Person
ImmunoPrecise will be attending Europe’s premier meeting for biologics and R&D, Biologics UK, September 6th-7th (+Digital Day: September 8th), 2021 in London. Learn more about the event here
June 10th, 2021
HubXchange West Coast 2021
We will be attending US West Coast HubXchange from September 20th-22nd 2021. HubXchange specializes in delivering high-level content, intelligence and connections to the global Life Sciences community by hosting outstanding business Xchanges. These...
June 7th, 2021
ImmunoPrecise Team to attend BIO Digital
Dr. Michael Spring, Frederic Chabot, Dr. Barry Duplantis, and Timothy Miller of ImmunoPrecise will be attending BIO Digital June10-11 & June 14-18, 2021. The event will host multiple speakers and one-on-one partnering meetings. BIO Digital will...
June 6th, 2021
ImmunoPrecise to Present at Antibody Engineering & Therapeutics Europe
At this year’s Antibody Engineering & Therapeutics Europe, Dr. Debby Kruijsen will be present the scientific briefing Identification of Unique Antibodies by Parallel Sourcing Chicken and Human B-cell Repertoires Using Innovative Technologies. Our...
May 10th, 2021
ImmunoPrecise attending HubXchange East 2021
ImmunoPrecise is attending HubXchange East being held in Boston May 17th-19th. HubXchange specializes in delivering high-level content, intelligence and connections to the global Life Sciences community by hosting outstanding business Xchanges....
April 28th, 2021
ImmunoPrecise To Attend Alliance For Cancer Gene Therapy Summit 2021
We are pleased to be attending the Alliance For Cancer and Gene Therapy Summit 2021. The summit is being held virtually April 29th 2021, containing multiple panels led by industry leaders to discuss the latest innovations in cancer drugs and...
April 27th, 2021
ImmunoPrecise Attending World Orphan Drug Congress
ImmunoPrecise will be attending the World Orphan Drug Congress, being held virtually April 28th, 2021. There will be a variety of panels and presentations throughout the day from industry experts. The conference is being held to advance the...
March 2nd, 2021
ImmunoPrecise To Participate in BiotechGate Digital Partnering Event
ImmunoPrecise will be participating in the Biotechgate Digital Partnering event being hosted virtually May 3-7, 2021. The digital partnering event is designed to support business development through pre-arranged 1-on-1 meetings. Learn more about the...
September 8th, 2020
IPA CEO to Participate in Virtual Panel: “New Approaches to COVID-19: Hidden Breakthroughs,” on Thursday, September 10th
VICTORIA, September 8, 2020 / – IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSX VENTURE: IPA) (OTCQB: IPATF) (FSE:TQB2), a leader in full-service, therapeutic antibody discovery and development, today announced that Dr. Jennifer Bath,...
October 18th, 2019
ImmunoPrecise Adopts Shareholder Rights Plan
VICTORIA, October 18, 2019 / – IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSX VENTURE: IPA) (OTCQB: IPATF), an industry leader in the discovery of novel, therapeutic antibodies, announces that its Board of Directors has adopted a...
October 14th, 2019
ImmunoPrecise Exhibiting at European Antibody Congress in Basel, October 15-19, 2019
ImmunoPrecise Antibodies will attend the Festival of Biologics held at the Congress Centre, Basel October 15-19th. The Festival of Biologics is a combination of four incredible conferences, the European Antibody Congress, the World Immunotherapy...
September 22nd, 2019
ImmunoPrecise to Lead Roundtable and Present Poster at 2019 West Coast Antibody Therapeutics Xchange
As innovative leaders in the field of antibody discovery, we are pleased to sponsor and lead group discussions at the 2019 West Coast Antibody Therapeutics Xchange. The unique format of hubXchange events formatting allows for a more in-depth...
August 29th, 2019
ImmunoPrecise Antibodies’ Annual Revenues Increase 100% to $10,926,268 Million
VICTORIA, August 28, 2019 / – IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSX VENTURE: IPA) (OTC PINK: IPATF) today reports its financial results for the year ended April 30, 2019. The financial statements and related Management’s...
June 10th, 2019
ImmunoPrecise Attending & Exhibiting at Antibody Engineering & Therapeutics Europe 2019
The ImmunoPrecise Antibodies team will be exhibiting at Antibody Engineering & Therapeutics (AET) Europe 2019 in Amsterdam, NL from June 11th-13th, 2019. AET Europe is the industry’s European meeting for Antibody and Protein Therapeutic Science,...
April 5th, 2019
ImmunoPrecise Attending & Exhibiting at #PEGS 19 in Boston, April 8-11
The 2019 Protein Engineering Summit (PEGS) in Boston is the industry’s preeminent event that inspires innovative biotherapeutic protein drug development. Plan to meet the IPA team at our booth (#622) to find out how to accelerate therapeutic...
March 20th, 2019
Meet Us at European Antibody Therapeutics Xchange
ImmunoPrecise to Lead Scientific Round-table Discussion and Poster Session at hubXchange’s European Antibody Therapeutics event. At hubXchange’s European Antibody Therapeutics event, held in Munich on March 21st, Dr. Debby Kruijsen will lead a...
February 27th, 2019
Meet Us at the Americas Antibody Congress 2019
ImmunoPrecise will be exhibiting at the Americas Antibody Congress 2019 at Festival of Biologics, a multi-streamed, co-located conference & technology exhibition March 4 – 5, 2019 at the Grand Hyatt, in San Diego, California. Connect with us at...
January 8th, 2019
Meet Us at PepTalk 2019
ImmunoPrecise will be attending PepTalk 2019, the Protein Science Week, from January 14-18th, 2019. PepTalk is the largest annual gathering of protein science researchers in the world. The conference focuses on intensive learning to discover new...
December 6th, 2018
Meet Us at Antibody Engineering & Therapeutics 2018
ImmunoPrecise will be attending Antibody Engineering & Therapeutics 2018, the annual meeting of The Antibody Society, where you can find the latest science, technologies and partners in antibody engineering, immunobiology, and next generation...
November 26th, 2018
ImmunoPrecise Antibodies Ltd. Discusses Target Customer Base and Growth Drivers in an Interview with StockNewsNow
ImmunoPrecise’s CEO and President, Dr. Jennifer Bath spoke with SNNLive at the SmallCap Discoveries Conference 2018 in Vancouver. Check Out the Video to Find out More On: The overview and history of ImmunoPrecise Antibodies, what makes IPA unique in...
Connect with IPA
Contact Us